Alzheimer's blood test study in Scotland

A landmark study called Bringing Alzheimer's Disease Biomarkers to General Practice (BriDGe) has launched in United Kingdom — Scotland, offering blood tests for Alzheimer s disease through GP surgeries. More than 50 GPs in central and northern United Kingdom — Scotland are participating, aiming to refer up to 500 patients. The tests, developed by F. Hoffmann-La Roche — Roche, detect proteins p-tau181 and p-tau217 in the blood, which reflect Alzheimer's-related brain changes. Led by Scottish Brain Sciences, the study seeks to speed up diagnosis, improve GP decision-making, and provide earlier access to support and treatments. The project is supported by F. Hoffmann-La Roche — Roche and involves researchers from the University of Edinburgh. Experts including Professor Craig Ritchie and Professor Tara Spires-Jones have praised the initiative as a major step forward in dementia diagnosis and treatment.